Immunocore Holdings PLC
- FMR LLC owns 3.6% of Immunocore
- FMR LLC beneficially owns 1,736,979 shares
- Abigail P. Johnson beneficially owns 1,736,979 shares
FMR LLC, filed by
IMCR
Immunocore Holdings plc SEC filings
Every EDGAR filing for Immunocore Holdings plc (IMCR), newest first, with AI summaries and stories.
- Ticker
- IMCR
- CIK
- 1671927
- Latest filing
- Oct 8
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 9)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINESCHEDULE 13G/AImmunocore Holdings plcIMCRLIVE ROUTINE8-KImmunocore Holdings plcIMCRLIVE ROUTINESCHEDULE 13G/AImmunocore Holdings plcIMCRLIVE Ownership stake disclosure by Vestal Point Capital, LP (amended)
Vestal Point Capital, LP, filed by
ROUTINESCHEDULE 13G/AImmunocore Holdings plcIMCRLIVE Ownership stake disclosure by WELLINGTON MANAGEMENT GROUP LLP (amended)
WELLINGTON MANAGEMENT GROUP LLP, filed by
ROUTINESCHEDULE 13G/AImmunocore Holdings plcIMCRLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
NOTABLE10-QImmunocore Holdings plcIMCRLIVE ROUTINE8-KImmunocore Holdings plcIMCRLIVE ROUTINE4Immunocore Holdings plcIMCRLIVE 6 insider filings
William Pao, insider filing for IMCR
Show all 6
- 4Insider filing for IMCR
- 4Insider filing for IMCR
- 4Insider filing for IMCR
- 4Insider filing for IMCR
- 4Insider filing for IMCR
- 4Insider filing for IMCR
William Pao, reporting
ROUTINE8-KImmunocore Holdings plcIMCRLIVE ROUTINE144Immunocore Holdings plcIMCRLIVE David M Berman, planned sale of IMCR shares
David M Berman, reporting
ROUTINE144Immunocore Holdings plcIMCRLIVE David M Berman, planned sale of IMCR shares
David M Berman, reporting
ROUTINESCHEDULE 13GImmunocore Holdings plcIMCRLIVE Ownership stake disclosure by Vestal Point Capital, LP
Vestal Point Capital, LP, filed by
ROUTINESCHEDULE 13G/AImmunocore Holdings plcIMCRLIVE Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)
T. Rowe Price Investment Management, Inc., filed by
ROUTINES-8Immunocore Holdings plcIMCRLIVE ROUTINE8-KImmunocore Holdings plcIMCRLIVE NOTABLE10-QImmunocore Holdings plcIMCRLIVE ROUTINEDEF 14AImmunocore Holdings plcIMCRLIVE ROUTINEARSImmunocore Holdings plcIMCRLIVE ROUTINE144Immunocore Holdings plcIMCRLIVE David M Berman, planned sale of IMCR shares
David M Berman, reporting
ROUTINE144Immunocore Holdings plcIMCRLIVE David M Berman, planned sale of IMCR shares
David M Berman, reporting
ROUTINESCHEDULE 13G/AImmunocore Holdings plcIMCRLIVE Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)
T. Rowe Price Investment Management, Inc., filed by
ROUTINE8-KImmunocore Holdings plcIMCRLIVE NOTABLE10-KImmunocore Holdings plcIMCRLIVE ROUTINE4Immunocore Holdings plcIMCRLIVE 5 insider filings
Travis Alan Coy, insider filing for IMCR
Show all 5
- 4Insider filing for IMCR
- 4Insider filing for IMCR
- 4Insider filing for IMCR
- 4Insider filing for IMCR
- 4Insider filing for IMCR
Travis Alan Coy, reporting
ROUTINE144Immunocore Holdings plcIMCRLIVE 3 Form 144 notices
David M Berman, planned sale of IMCR shares
Show all 3
- 144Planned insider sale of IMCR shares
- 144Planned insider sale of IMCR shares
- 144Planned insider sale of IMCR shares
David M Berman, reporting
ROUTINESCHEDULE 13G/AImmunocore Holdings plcIMCRLIVE Ownership stake disclosure by T. Rowe Price Investment Management, Inc. (amended)
T. Rowe Price Investment Management, Inc., filed by
ROUTINE8-KImmunocore Holdings plcIMCRLIVE ROUTINE8-KImmunocore Holdings plcIMCRLIVE ROUTINE4Immunocore Holdings plcIMCRLIVE David M Berman, insider filing for IMCR
David M Berman, reporting
ROUTINE4Immunocore Holdings plcIMCRLIVE David M Berman, insider filing for IMCR
David M Berman, reporting
ROUTINE8-KImmunocore Holdings plcIMCRLIVE ROUTINE4Immunocore Holdings plcIMCRLIVE David M Berman, insider filing for IMCR
David M Berman, reporting
ROUTINE144Immunocore Holdings plcIMCRLIVE Immunocore Holdings plc filed Form 144 (Proposed Securities Sale)
- Notice of proposed sale of securities
- Required for restricted stock sales
David M Berman, reporting
ROUTINESCHEDULE 13GImmunocore Holdings plcIMCRLIVE Bellevue Group AG filed a Schedule 13G disclosing a 5.1% ownership stake in Immunocore Holdings plc (IMCR), a clinical-stage biopharmaceutical company.
Bellevue Group AG, filed by
ROUTINE8-KImmunocore Holdings plcIMCRLIVE NOTABLE10-QImmunocore Holdings plcIMCRLIVE